A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and reduced use of crucial...

New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...

WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients,...

Quantum BioPharma (CSE:QNTM) will conduct a study observing disease progression in patients with primary progressive multiple sclerosis.

Researchers conducted a groundbreaking phenomenological study to delve into the experiences of autistic adults who had been misdiagnosed with...

Early high-efficacy treatment drastically lowers long-term disability risk in children with multiple sclerosis, offering better outcomes for their...

The connection between medlinkdiabetes/medlink and medlinkperiodontal disease/medlink is well-established, but the effect of diabetes treatment on...

Novel combination of medlinkdecitabine/medlink, medlinkvenetoclax/medlink, and medlinkponatinib/medlink achieved bone marrow remission in

North Korea has begun a nationwide medlinkvaccination/medlink campaign for medlinkchildren/medlink and medlinkpregnant women/medlink, aided by...